NASACORT ALLERGY 24 HOUR Drug Patent Profile

✉ Email this page to a colleague

When do Nasacort Allergy 24 Hour patents expire, and when can generic versions of Nasacort Allergy 24 Hour launch?

Nasacort Allergy 24 Hour is a drug marketed by Chattem Sanofi and is included in one NDA.

The generic ingredient in NASACORT ALLERGY 24 HOUR is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Seventy-four suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Nasacort Allergy 24 Hour

A generic version of NASACORT ALLERGY 24 HOUR was approved as triamcinolone acetonide by TARO on October 1^st, 1986.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for NASACORT ALLERGY 24 HOUR?
What are the global sales for NASACORT ALLERGY 24 HOUR?
What is Average Wholesale Price for NASACORT ALLERGY 24 HOUR?

Summary for NASACORT ALLERGY 24 HOUR

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	82
Clinical Trials:	8
Patent Applications:	4,298
DailyMed Link:	NASACORT ALLERGY 24 HOUR at DailyMed

Drug patent expirations by year for NASACORT ALLERGY 24 HOUR

Recent Clinical Trials for NASACORT ALLERGY 24 HOUR

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Gail Gauvreau	N/A
Stanford University	Phase 4
Sanofi	Phase 4

See all NASACORT ALLERGY 24 HOUR clinical trials

Pharmacology for NASACORT ALLERGY 24 HOUR

Drug Class	Corticosteroid
Mechanism of Action	Corticosteroid Hormone Receptor Agonists

US Patents and Regulatory Information for NASACORT ALLERGY 24 HOUR

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chattem Sanofi	NASACORT ALLERGY 24 HOUR	triamcinolone acetonide	SPRAY, METERED;NASAL	020468-002	Oct 11, 2013		OTC	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for NASACORT ALLERGY 24 HOUR

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Chattem Sanofi	NASACORT ALLERGY 24 HOUR	triamcinolone acetonide	SPRAY, METERED;NASAL	020468-002	Oct 11, 2013	⤷ Sign Up	⤷ Sign Up
Chattem Sanofi	NASACORT ALLERGY 24 HOUR	triamcinolone acetonide	SPRAY, METERED;NASAL	020468-002	Oct 11, 2013	⤷ Sign Up	⤷ Sign Up
Chattem Sanofi	NASACORT ALLERGY 24 HOUR	triamcinolone acetonide	SPRAY, METERED;NASAL	020468-002	Oct 11, 2013	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for NASACORT ALLERGY 24 HOUR

See the table below for patents covering NASACORT ALLERGY 24 HOUR around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
China	1235568		⤷ Sign Up
Czech Republic	9804377		⤷ Sign Up
South Korea	20000023563		⤷ Sign Up
African Intellectual Property Organization (OAPI)	10950	Aqueous-based pharmaceutical composition	⤷ Sign Up
Portugal	938345		⤷ Sign Up
Brazil	9710115	composiÇço aquosa farmacÊutica, e processo de preparaÇço de uma composiÇço aquosa farmacÊutica.	⤷ Sign Up
Hong Kong	1022652		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for NASACORT ALLERGY 24 HOUR

Recent Clinical Trials for NASACORT ALLERGY 24 HOUR

Pharmacology for NASACORT ALLERGY 24 HOUR

Make Better Decisions: Try a trial or see plans & pricing